Status:
COMPLETED
External Counterpulsation (ECP) for the Promotion of Collateral Growth in Patients With Coronary Artery Disease
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The purpose of this study in humans with stable coronary artery disease (CAD) treatable by percutaneous coronary intervention (PCI) is to evaluate the efficacy of External Counterpulsation (ECP) with ...
Detailed Description
Alternative strategies for the promotion of coronary collaterals (arteriogenesis) are a promising therapeutic alternative for at least 20% of all Patients with Coronary Artery Disease (CAD). Beside gr...
Eligibility Criteria
Inclusion
- Age \> 18 years old
- 1- to 3-vessel coronary artery disease (CAD)
- Stable angina pectoris
- At least 1 stenotic lesion suitable for PCI within the next 4 weeks
- No Q-wave myocardial infarction in the area undergoing CFI measurement
- Written informed consent to participate in the study
Exclusion
- Patients admitted as emergencies
- Acute myocardial infarction within the last 3 months
- Unstable CAD
- CAD treated best by CABG
- Coronary stenotic lesion to be treated ad-hoc or within \< 4 weeks
- Severe valve disease
- Pulmonary artery hypertension
- Congestive heart failure
- Atrial fibrillation
- Thrombophlebitis and/or deep vein thrombosis
- Occlusive peripheral artery disease
- Abdominal aortic aneurysm
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00414297
Start Date
August 1 2006
End Date
June 1 2009
Last Update
October 26 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bern University Hospital
Bern, Switzerland, 3010